We analysed the involvement of proteases during taxolmediated cell death of human A549 non-small-cell lung carcinoma cells using a proteomics approach that specifically targets protein N termini and further detects newly formed N termini that are the result of protein processing. Our analysis revealed 27 protease-mediated cleavages, which we divided in sites C-terminal to aspartic acid (Asp) and sites C-terminal to non-Asp residues, as the result of caspase and non-caspase protease activities, respectively. Remarkably, some of the former were insensitive to potent pancaspase inhibitors, and we therefore suggest that previous inhibitor-based studies that report on the caspaseindependent nature of taxol-induced cell death should be judged with care. Furthermore, many of the sites C-terminal to non-Asp residues were also uniquely observed in a model of cytotoxic granule-mediated cell death and/or found by in vitro cataloging human l-calpain substrates using a similar proteomics technique. This thus raises the hypothesis that killing tumor cells by chemotherapy or by immune cells holds similar non-Asp-specific proteolytic components with strong indications to calpain activity.
Introduction
Chemotherapeutic agents kill tumor cells by different forms of programmed cell death (PCD). Next to apoptosis with activation of the caspase cascade as the most studied form, alternatives such as 'apoptosis-like PCD' and 'necrosis-like PCD' have been described (Leist and Jaattela, 2001 ). These modes of PCD are characterized by an essential activity of proteases other than caspases during the onset or execution phase of cell death. For example, cathepsins (Foghsgaard et al., 2001; Bidere et al., 2003; Broker et al., 2004) , calpains (Karmakar et al., 2007; Pineiro et al., 2007 ) and yet uncharacterized proteases (de Bruin et al., 2003) were reported to play key roles in different cell death models.
One class of chemotherapeutic drugs that induce such alternative forms of PCD is microtubule-stabilizing agents with their prototypical representative taxol (paclitaxel). Taxol and derivatives are used as potent drugs against several solid tumors. Although their cytotoxic mechanism depends on cell type, concentration and exposure duration, in most studies with clinically relevant taxol concentrations (10-200 nM), apoptosis is induced by blocking the mitotic spindle and a G2/M arrest (Schiff and Horwitz, 1980; Torres and Horwitz, 1998; Blagosklonny and Fojo, 1999; Zhao et al., 2005) . The signaling pathways leading to cell death have been extensively studied (Blagosklonny and Fojo, 1999; Zhao et al., 2005) and recently several papers on the proteases involved were published. It is now clear that taxol triggers apoptosis by both caspasedependent (Park et al., 2004; Ehrlichova et al., 2005; Li et al., 2005; Lu et al., 2005; Day et al., 2006; Janssen et al., 2007; Pineiro et al., 2007) and caspase-independent pathways (Broker et al., , 2004 Huisman et al., 2002; Ofir et al., 2002) . One of the main supporting observations for the latter is the failure of the pancaspase inhibitor zVADfmk (N-benzyloxycarbonylVal-Ala-Asp(O-Me) fluoromethyl ketone) to protect against taxol-induced apoptosis Huisman et al., 2002) .
Here, we identified protease substrates targeted during taxol treatment of human A549 non-small-cell lung carcinoma cells using the peptide-centric proteomics technique known as N-terminal COFRADIC (COmbined FRActional DIagonal Chromatography) . This method specifically isolates (neo-)N-terminal peptides from digested proteomes before identification by tandem mass spectrometry (Gevaert et al., 2003) and has proven to be a powerful tool for substrate degradome analysis (Lopez-Otin and Overall, 2002; Van Damme et al., 2005; Vande Walle et al., 2007) : not only the protein substrates but also the exact cleavage sites are simultaneously assigned, providing links to the functional implication of the cleavage events and to the type(s) of protease(s) creating the cleavage patterns.
Results

Treatment with taxol results in detachment and apoptosis of G2/M-arrested A549 cells
Twenty-four hours after induction with 200 nM taxol, a fraction of A549 cells had detached from the culture dish and died during the next 24 h, whereas a significant fraction of cells remained attached and did not show any apoptotic alterations, even after 48 h (Figure 1 ). Cell cycle analysis by flow cytometry revealed that detachment and associated cell death was the result of a mitotic arrest in the G2/M phase. This was not the case for adherent cells, where next to a limited increase in G2/Mphase cells, a significant fraction of the cell population resided in other phases of the cell cycle (Figure 1 ). Besides the fact that the latter stopped dividing and that stress granules were formed, no signs of PCD were present.
Time course flow cytometry experiments (Figure 2 ) further confirmed that detached cells were dying by apoptosis, as a high proportion of these cells stained positive for annexin V and showed a hypoploid (sub-G1) DNA content at early time points (p24 h). A large fraction of these cells became positive for propidium iodide (PI) only at late time points (X48 h). In adherent cells, we measured a rather slow increase over time for all parameters; however, the remarkable changes between 24 and 48 h observed for detached cells as a result of the execution phase of cell death are not present, pointing to stress conditions without triggering cell death. Together, these observations clearly indicate the need to distinguish between detached and adherent A549 cell populations for further substrate degradomics.
Lysosomal membrane permeabilization and activation of caspase-3 and calpains occur only in detached cells Next to caspases (Park et al., 2004; Ehrlichova et al., 2005; Li et al., 2005; Lu et al., 2005; Day et al., 2006; Janssen et al., 2007; Pineiro et al., 2007) , involvement of calpains (Pineiro et al., 2007) and cathepsin-B (Broker et al., 2004) was described in taxol-induced apoptosis. We compared taxol-treated detached and adherent A549 cells for activation of caspase-3 and calpains on immunoblots (Figure 3a ). Lysosomal membrane permeabilization (LMP) and intracellular calcium Substrate degradomics of taxol-treated A549 cells F Impens et al concentration were measured by flow cytometry as a decrease in red fluorescence of acridine orange (AO) and an increase in green fluorescence of Fluo-4, respectively ( Figure 3b ). Detached cells treated for 48 h with taxol showed activation of procaspase-3 as observed by the presence of two processed forms of the large caspase-3 subunit. Consistent with previous studies, we confirmed that this was accompanied by activation of the intrinsic mitochondrial apoptotic pathway as observed by the cleavage of Bid and release of cytochrome c in the cytosol Park et al., 2004 ) (data not shown). Activation of the classical calpains (m-and m-calpain) was initiated 24 h after taxol treatment and was clearly visible after 48 h as shown by the formation of smaller autolytic fragments of the common small calpain subunit (Wood and Newcomb, 1999) . Flow cytometry revealed that the activation of calpains was accompanied by an increase of intracellular calcium concentration. Finally, by measuring AO fluorescence, we observed LMP between 24 and 48 h in detached cells.
No evidence for the activation of proteases involved in cell death or LMP in adherent cells was obtained, in line with the fact that no PCD was observed in these cells (Figure 2 ). Based on these results, we screened for protease substrates in 48 h taxol-treated detached A549 cells.
Screening by N-terminal COFRADIC in taxol-treated detached A549 cells identified 27 processed sites in 22 proteins Two proteomic screens were performed using N-terminal COFRADIC (Gevaert et al., 2003 (Staes et al., 2004) . In the second screen, cells were metabolically labeled during cell culture by SILAC (stable isotope labeling by amino acids in cell culture) (Ong et al., 2002) with light ( 12 C 6 , taxol-treated) or heavy ( 13 C 6 , control) arginine, introducing a mass difference of 6 Da. In both setups, equal amounts of control and taxol-treated samples were mixed before N-terminal peptide sorting and MALDI-MS/MS (matrix assisted laser desorption ionization tandem mass spectrometry) or ESI-MS/MS (electrospray ionization tandem mass spectrometry) for the first and second screens, respectively.
Using this differential setup, levels of N termini in control and treated cells were compared and singletons or neo-N-termini in the proteome digest of detached A549 cells specifically pointed to processed proteins (Van Damme et al., 2005; Vande Walle et al., 2007) (Table 1) . Two major classes were distinguished: (1) 16 processed sites C-terminal to aspartic acid (Asp), 8 of which were previously reported among others in Fastreated Jurkat cells and are considered caspase cleavage sites (Van Damme et al., 2005) and (2) 11 processed sites C-terminal to other residues, 10 of which are hitherto unreported.
Caspases process proteins in taxol-treated A549 cells, although their activity cannot completely be inhibited To validate our proteomics data, we selected proteins containing hitherto unreported cleavage sites and for which antibodies were available (plectin, microtubuleassociated protein 1B (MAP1B) and clathrin light chain A (CLCA)) to monitor alterations or destructions of epitopes by proteases using western blots.
Plectin migrates with an apparent molecular weight much lower than estimated from its sequence containing 4684 residues (Pytela and Wiche, 1980) . For unexplained Substrate degradomics of taxol-treated A549 cells F Impens et al reasons, plectin migrated as a doublet. We observed a time-dependent appearance of a plectin fragment (at ±250 kDa; Figure 4a ) which, given the epitope recognized by the monoclonal antibody, may well correspond to the expected C-terminal plectin fragment. Furthermore, this fragment shows a near-perfect overlap with the predicted C-terminal globular domain of plectin for which a more normal electrophoretic mobility is expected compared to the intact protein carrying an extensive rod domain. A similar time-dependent production of fragments or disappearance of precursors was noticed for MAP1B and CLCA (Figure 4a ). For MAP1B, a fragment at ± 210 kDa was generated in accordance with the size of the N-terminal fragment formed by a cleavage at position 1859 (Table 1) . Experiments on the CLCA revealed two bands that were probably the intact isoforms A and B, both recognized by the antibody. The identified cleavage site is unique for the isoform A.
Yet we observed the disappearance of epitopes in both forms, which could indicate that processing of the isoform B was such that a neo-N-terminus was created that was not analysable by our technique.
None of these processing events were detected in lysates from adherent cells under taxol treatment, and none of them, which, given the nature of the processed sites, most likely resulted from caspase activity, were inhibited by zVADfmk (Figure 4a ). Even the formation of a C-terminal epitope by cleavage of cytokeratin (KRT)18 at Asp-397 (Leers et al., 1999) , considered highly diagnostic for caspase activity, was not prevented. Also, cleavage of the classical caspase substrate poly (ADP-ribose) polymerase (PARP) to its p85 fragment was present in this condition ( Figure 4a ) (Nicholson et al., 1995) . These unexpected observations indicate that zVADfmk did not work or that a significant portion of caspase activity was not inhibited by caspase inhibitors. Substrate degradomics of taxol-treated A549 cells F Impens et al Abbreviations: Asp, aspartic acid; ESI-MS/MS, electrospray ionization tandem mass spectrometry; MALDI-MS/MS, matrix assisted laser desorption ionization tandem mass spectrometry. SwissProt accession number, sequence of the identified neo-N-terminal peptide ('Ac-' denotes a-amino-acetylation), start and end position of the peptide in the protein sequence, the four amino acids preceding the cleavage site, protein description and the number of spectra by which each peptide was identified in both analyses (including the highest MASCOT scoreÀthreshold score) are indicated. Sites previously reported in Fas-treated Jurkat cells are indicated.
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We ruled out the former, as in taxol-treated detached cells polypyrimidine tract-binding protein 1 (PTBP1) and TIF1-b, two known caspase substrates (Van Damme et al., 2005) , were cleaved with the generation of correctly sized fragments (also observed in Fastreated Jurkat cells, see Figure 4b ) and these cleavages were inhibited by zVADfmk. Furthermore, in lysates of taxol-treated cells, zVADfmk concentrations as low as 25 mM completely abolished general DEVDase activity (Figure 4c) . To exclude the possibility of protein processing being done by caspase-2, a member of the caspase family poorly inhibited by zVADfmk (GarciaCalvo et al., 1998), we used its specific inhibitor zVDVADfmk (N-benzyloxycarbonyl-Val-Asp(O-Me)-Val-Ala-Asp(O-Me) fluoromethyl ketone) and showed that plectin processing and formation of the M30 KRT18 epitope were again not inhibited. Additionally, broad-spectrum protease inhibitors such as E64-d (cysteine proteases), AEBSF (serine proteases) and Substrate degradomics of taxol-treated A549 cells F Impens et al pepstatin (aspartate proteases) had no or limited effect (Figure 4d ).
Several non-Asp sites are found in cytotoxic granule-mediated cell death
In addition to the Asp-specific sites, 11 non-Asp sites were identified in which cleavage occurred C-terminal to various residues, suggesting activities of several broad-spectrum proteases (Table 1) . Selected cases were validated by immunoblotting in detached cells ( Figure 5 ). Lysosomes share a lot of their protein content with more specialized cytotoxic granules, which can be considered as secretory lysosomes in natural killer cells and CD8 þ cytotoxic T lymphocytes. Next to granulespecific proteases (for example, granzymes), several ubiquitously expressed lysosomal proteases (for example, cathepsins) reside in these granules (Smyth et al., 2001) . Given the occurrence of LMP in our model (Figure 3 ) and the overlapping proteolytic content of lysosomes and cytotoxic granules, we searched for common substrates in other cell death models. Therefore, we compared the processed sites found here with those observed during Fas-induced apoptosis in human Jurkat (Table 2 ). For instance, of the 38 sites detected in dying K562 cells, 5 were also identified in A549 cells: in reticulon-4, PTBP1, KRT8 and KRT18. Apart from cleavage of PTBP1 at Met-175 in Fasinduced apoptosis in Jurkat cells (Van Damme et al., 2005) , these sites were never found in our studied models. Furthermore, five additional sites were found in KRT8 and KRT18 of K562 cells (Table 2) . It is worth mentioning that although we could confirm KRT8 and KRT18 processing by immunoblotting in A549 cells, we failed to do this in cell lysates of apoptotic K562 cells. This could be due to the low abundance of these proteins in K562 cells and the overall greater sensitivity of mass spectrometry-based proteomics (Enoksson et al., 2007) .
As suggested above, the striking substrate overlap between taxol-induced A549 cell death and cytotoxic granule-mediated K562 cell death points to activation of a similar protease mechanism, most likely derived from lysosomal or cytotoxic granule origin. Additionally, we found that calpains cannot be excluded as part of this common activity, as these proteases are activated not only in taxol-treated A549 cells (Figure 3 ) but also in the coculture model (data not shown). By screening for substrates of human m-calpain in A549 cell lysates with N-terminal COFRADIC, we identified several KRT cleavage sites also reported here (Table 2 ). For this latter experiment, freeze-thaw lysates of A549 cells with a total protein concentration of 2 mg/ml were incubated for 20 min at 37 1C with 200 nM human m-calpain (treated) or 1 mM EDTA (control) (F Impens et al., unpublished data). Taken together, these results therefore indicate that classical calpains play a prominent role in both studied cell death models and that their activity is responsible for the observed cleavage sites in KRT8 and KRT18.
Discussion
Previous reports indicated the activation and involvement of different protease families in the execution of taxol-induced cell death. However, such studies were generally fragmentary and often led to different conclusions. To obtain a more general picture, we analysed lysates from A549 cells treated with taxol for 48 h. Our analyses were unique, as both substrates and their cleavage sites were identified, providing two levels of information: substrates link to possibly lost or altered biological functions and cleaved sites may point to the proteases involved.
We showed that mitotic arrest, apoptosis and proteolytic activity are exclusively observed in cells that detached from the culture dish and not in adherent cells (Figures 1-3) . Thus, not discriminating between detached and adherent non-small lung cancer cells upon taxol treatment (Broker et al., , 2004 ) may lead to incomplete results.
The protease substrates identified here comprise proteins with different functions (Table 1) . Cytoskeletal proteins form an important though not dominant class. The intermediate filament components vimentin and the keratins 8, 18 and 19 are examples and the microtubuleinteracting proteins MAP1B and TPPP/p25 represent a second cytoskeletal network. Plectin is the cytolinker interconnecting the different elements. Our results suggest disintegration of the cytoskeleton and could explain loss of cellular adhesive capacity. However, following 24 h of taxol incubation, a stage where cells have already detached, very little proteolytic fragmentation of these cytoskeletal proteins was detected. Therefore, probably not extensive cytoskeletal fragmentation but rather the signaling cascades following mitotic arrest acting early in the cell death process could be the primary cause of cell detachment.
Several substrates with important nuclear functions were identified: in particular, SPHAR (S-phase responsive protein) and nucleosome assembly protein 1-like 1 (NAP-1). Loss of SPHAR function reduces the rate of DNA synthesis during S phase and causes G2-phase prolongation (Digweed et al., 1995) . NAP-1 is important for chromatin assembly and cell cycle regulation. This, together with the microtubule-stabilizing activity of taxol, could reinforce mitotic arrest of taxol-treated cells. Previously, spliceosome components were found to be the preferred protease targets (Van Damme et al., 2005) . Here, we only identified RNA binding protein FUS (FUS) and PTBP1 cleaved at the same site as found before, strongly suggesting the involvement of Substrate degradomics of taxol-treated A549 cells F Impens et al Substrate degradomics of taxol-treated A549 cells F Impens et al caspases. Two further interesting substrates are NSFL1/ p47 and reticulon-4 (Nogo), both associated with membranes or membrane proteins (Kondo et al., 1997; Yan et al., 2006) and whose cleavage could be in line with the lysosomal permeability observed after taxol treatment. Overall, our substrate list may be the source for future experiments in which some of the hypotheses forwarded here could be verified.
The 27 identified cleavage sites were divided into two groups. The first group contains Asp sites located at caspase consensus motifs. It is important to note here that, as can be assessed by MEROPS (http://merops. sanger.ac.uk), the ability of human intracellular proteases to cleave after aspartic residues is mainly a feature of caspases and granzyme B. Eight such Asp sites were reported previously (Van Damme et al., 2005) , whereas eight are new. Quite surprisingly, some of the latter (cleavage of MAP1B (LEKDk), CLC (DAVDk) and plectin (DALDk)) were not inhibited by the wellknown, potent caspase inhibitor zVADfmk (Figure 4a) . Interestingly, when A549 lysates were assayed with the M30 KRT18-specific antibody in the presence of this inhibitor, the specific KRT18 fragment appeared, indicating that cleavage at a site highly diagnostic for caspase activity was not blocked (Figure 4a) . Likewise, the remaining PARP cleavage was observed under these conditions. When the same lysates were assayed with anti-PTBP1 and anti-TIF1-b antibodies, inhibition of processing occurred (Figure 4b ), indicating that our previous results were not due to inadequately working pancaspase inhibitors but rather to kinetic effects leading to failure of inhibition of certain members of the caspase family. The additional lower band observed with the M30 KRT18 antibody in conditions with zVADfmk ( Figure 4d ) also points to such effects, as it suggests efficient inhibition of caspase cleavage at Asp-238 but not at Asp-397 detected by the antibody (assuming that cleavage at one of the non-Asp sites near the N terminus of the protein (Table 2) is responsible for the lower molecular weight band). Such remaining caspase activity might explain the often contradictory results concerning caspase dependency in taxol-induced cell death (Broker et al., , 2004 Huisman et al., 2002; Ofir et al., 2002; Park et al., 2004; Ehrlichova et al., 2005; Lu et al., 2005; Day et al., 2006; Pineiro et al., 2007) : in the presence of zVADfmk, together with non-Asp-specific proteases, this activity will still contribute to cell death in which some caspase cleavage events are prevented (for example, PTBP1 and TIF1-b), whereas others are still observed (for example, PARP and M30 KRT18; Figure 4 ). The reason that caspase inhibitors are not eliminating all of their targeted protease activity can be due to the fact that in our model other classes of massively activated proteases, such as calpains and cathepsins, might compete for their binding (inhibition of cathepsins by zVADfmk has been described; Schotte et al., 1999) . Therefore, these results again illustrate that conclusions based on (unspecific) protease inhibitors should be judged with care in models where many different proteases are activated simultaneously and, in particular, in models of taxol-induced cell death.
The second group of cleavage sites is characterized by a diverse set of non-Asp residues at the P1 position, including small hydrophilic, bulky hydrophobic and basic residues. Among these, we detected two processing events C-terminal to proline. Several of these sites overlap with sites that were identified in a model of cytotoxic granule-mediated cell death and with an in vitro catalog of m-calpain substrates (Table 2 and F Impens et al., unpublished data). These findings thus suggest the action of a heterogeneous pool of proteases in which calpains play a prominent role, although cathepsins cannot be excluded. Therefore, we believe that our finding of an unusual number of common cleavage sites suggests overlapping mechanisms of protease release or activation in taxol-induced cell death and immune-based cytotoxicity.
Materials and methods
Materials
Taxol (from Taxus yunnanensis; Sigma-Aldrich, St Louis, MO, USA), zVADfmk (Sigma-Aldrich), zVDVADfmk (R&D Systems, Minneapolis, MN, USA) and E64-d (loxistatin; Biotrend Chemikalien, Cologne, Germany) were dissolved in dimethyl sulfoxide and stored at À20 1C. A fresh solution in water was made before use for AEBSF (aminoethylbenzenesulfonyl fluoride hydrochloride; Sigma-Aldrich). Pepstatin A (Serva, Heidelberg, Germany) was dissolved in 10% acetic acid in dimethyl sulfoxide. Protease inhibitor cocktail tablets were from Roche Diagnostics (Mannheim, Germany). Protein concentrations were measured by the Bio-Rad DC Protein Assay Kit from Bio-Rad (Mu¨nchen, Germany). Antibodies against the following proteins were used: caspase-3 (rabbit polyclonal, 1/4000; Stressgen, Ann Arbor, MI, USA), calpain small subunit (mouse monoclonal, 1/1000; Calbiochem, Nottingham, UK), PARP (mouse monoclonal, 1/3000; Biomol, Plymouth, PA, USA), plectin (mouse monoclonal, 1/300; BD Biosciences, San Jose, CA, USA), MAP1B (mouse monoclonal, 1/750; Abcam plc, Cambridge, UK), CLC (mouse monoclonal, 1/1000; Abcam), M30 KRT18 CytoDEATH (mouse monoclonal, 1/1000; Alexis, Lausen, Switzerland), TIF1-b (KAP1, rabbit polyclonal, 1/2000; Abcam), PTBP1 (mouse monoclonal, 1/500; Abcam), KRT8 (mouse monoclonal, 1/1500; Abcam), KRT18 (mouse monoclonal, 1/1500; Abcam). Secondary antibodies (1/2000 dilution) against mouse and rabbit antibodies were from Abcam and from DAKOpatts (Copenhagen, Denmark) against goat antibodies.
Cell culture, SILAC labeling and taxol treatment of A549 cells A549 cells (ATCC, Manassas, VA, USA) were grown in F12-K medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal calf serum (Lonza, Verviers, Belgium), 50 IU/ ml penicillin and 50 mg/ml streptomycin (Invitrogen). TrypsinVersene (EDTA) (Lonza) was used to detach cells, except for the proteome analyses where Versene (EDTA) solution (Lonza) was used to detach control cells. SILAC labeling was performed by growing cells for at least six population doublings in arginine-free F12-K medium (Invitrogen), supplemented with 10% dialysed fetal calf serum (Invitrogen), 50 IU/ml penicillin, 50 mg/ml streptomycin and 0.3 mM light ( 12 C 6 , from normal F12-K medium) or heavy ( 13 C 6 ) When taxol induction was started, control cells were typically passaged frac14; and cultured for another 48 h. As the dimethyl sulfoxide concentration in cell culture due to induction with 200 nM taxol was below 0.0005% and had no cytotoxic effect or influence on cell growth, the vehicle was added only to control cells in the highest concentration when experiments with protease inhibitors were performed.
Cell culture and Fas treatment of Jurkat cells Experiments were performed as described before (Van Damme et al., 2005) .
Cell cycle analysis and measurement of hypoploid DNA content For cell cycle analysis, the protocol of Krishan (1990) was followed. Isolated nuclei stained with PI were measured by flow cytometry upon excitation at 488 nm (FACScalibur using CELLQuest software from BD Biosciences). Measurement of the hypoploid DNA content was performed the same way, except that whole cells were analysed (cells were frozen at À80 1C in the presence of 20 mg/ml PI in phosphatebuffered saline before FACS measurement). The result of one experiment is shown as the average value of at least three biological replicates. Trends were confirmed in an independent analysis.
Annexin V and PI measurement
The annexin V FITC Apoptosis Detection kit from Calbiochem was used. A549 cells were treated with taxol as described above. Samples were prepared and measured by flow cytometry according to the manufacturer's instructions. The result of one experiment is shown as the average value of at least two biological replicates.
Measurement of LMP and intracellular calcium A549 cells were treated with taxol as described above. Cells were loaded by the addition of AO and Fluo-4 (Invitrogen) directly to cell culture media (5 mg/ml AO, 12.5 mM Fluo-4) 30 min before measurement by flow cytometry upon excitation at 488 nm (FACScalibur using CELLQuest software). LMP was measured as a decrease in red AO fluorescence (Zhao et al., 2000) , whereas an increase in intracellular Ca 2 þ was measured as an increase in green Fluo-4 fluorescence (Pineiro et al., 2007) .
Measurement of DEVDase activity
The caspase-glo 3/7 assay from Promega was used according to the manufacturer's instructions. A549 cells were treated with taxol in 96-well plates, and therefore no distinction was made between detached and adherent cells. The result of one experiment is shown as the average value of four biological replicates and was confirmed in an independent analysis.
Immunoblotting
Harvested cells were lysed on ice for 15 min in 0.8% CHAPS, 50 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; pH 7.4), 100 mM NaCl, 0.5 mM EDTA supplemented with a complete protease inhibitor cocktail tablet (1/100 ml). Lysates were centrifuged for 15 min at 16 000 g at 4 1C and pellets were discarded. Equal amounts of total protein were separated on 4-12% Criterion XT gels in MOPS buffer (BioRad) at 150 V and transferred overnight in 50 mM Tris 50 mM boric acid at 10 V onto a polyvinylidene difluoride membrane. Protein detection was performed using standard protocols for membrane blocking, antibody incubation and film development.
Protein extraction and COFRADIC isolation of N-terminal peptides For both proteomic screens, A549 cells were treated for 48 h with 200 nM taxol. Detached cells as well as untreated control cells were harvested as described above. Cells were lysed on ice for 15 min in the CHAPS lysis buffer as described above. After centrifugation at 16 000 g for 15 min at 4 1C, the total protein concentration in the supernatant was measured and the protocol was continued with equal amounts of total protein material of control and treated sample (2 mg for both screens). For the first analysis, the unlabeled control and treated sample were prepared separately until oxygen-18 labeling (Staes et al., 2004) , whereas for the second analysis, SILAC-labeled proteome samples were mixed directly after lysis. Isolation of N-terminal peptides by COFRADIC was performed as described previously (Gevaert et al., 2003; Van Damme et al., 2005) .
MS/MS analysis MALDI-MS/MS was performed on oxygen-16/18-labeled samples as described before, except for some minor changes in the automated MS/MS measurements using the Bruker Ultraflex II TOF/TOF MALDI mass spectrometer under control of Bruker's WarpLC software : after MS measurement, 3937 MS/MS spectra were recorded from peptides present as singletons or as significantly regulated couples (as assessed by the WARP-LC 1.0 software). LC-ESI-MS/MS (liquid chromatography ESI-MS/MS) analysis was performed on SILAC-labeled samples as described before (Ghesquiere et al., 2006) . Here, 24 022 MS/MS spectra were recorded.
MASCOT peptide identification
Fragmentation spectra were searched using a local version of MASCOT (http://www.matrixscience.com). Spectra were searched in the human SwissProt database (version 49.0 (MALDI-MS/MS) or version 50.4 (ESI-MS/MS), downloaded from ftp://ftp.ebi.ac.uk/pub/databases/uniprot/knowledgebase/ uniprot_sprot.dat.gz) and the human International Protein Index (IPI) database (version 3.14 (MALDI-MS/MS) or version 3.19 (ESI-MS/MS), downloaded from ftp://ftp. ebi.ac.uk/pub/databases/IPI/current/ipi.HUMAN.dat.gz) as well as in their N-terminally truncated peptide databases made by DBtoolkit . Peptide identifications were performed as described before (Van Damme et al., 2005; Vande Walle et al., 2007) . For the MALDI-MS analysis, we identified 270 spectra belonging to 224 unique peptides in 193 unique proteins. For the ESI-MS/MS analysis, we identified 2227 spectra belonging to 1219 unique peptides in 897 unique proteins. All peptide identifications are made publicly available via the PRIDE database (http://www.ebi.ac.uk/pride/) (experiment numbers 2408 and 2409).
